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Available online 31 March 2016Inﬂammatory signaling may play a role in high-fat diet (HFD)-related circadian clock disturbances that contrib-
ute to systemicmetabolic dysregulation. Therefore, palmitate, the prevalent proinﬂammatory saturated fatty acid
(SFA) in HFD and the anti-inﬂammatory, poly-unsaturated fatty acid (PUFA), docosahexaenoic acid (DHA), were
analyzed for effects on circadian timekeeping and inﬂammatory responses in peripheral clocks. Prolonged palmi-
tate, but not DHA, exposure increased the period of ﬁbroblast Bmal1-dLuc rhythms. Acute palmitate treatment
produced phase shifts of the Bmal1-dLuc rhythm that were larger in amplitude as compared to DHA. These
phase-shifting effects were time-dependent and contemporaneous with rhythmic changes in palmitate-
induced inﬂammatory responses. Fibroblast and differentiated adipocyte clocks exhibited cell-speciﬁc differ-
ences in the time-dependent nature of palmitate-induced shifts and inﬂammation. DHA and other inhibitors of
inﬂammatory signaling (AICAR, cardamonin) repressed palmitate-induced proinﬂammatory responses and
phase shifts of the ﬁbroblast clock, suggesting that SFA-mediated inﬂammatory signalingmay feed back to mod-
ulate circadian timekeeping in peripheral clocks.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Adipocytes1. Introduction
Over-nutrition, especially through the consumption of aHFD, is a crit-
ical factor in the rapidly increasing incidence of obesity. HFD-induced
obesity is associated with systemic insulin resistance and the corre-
sponding development of metabolic disorders such as type 2 diabetes,
cardiovascular disease and non-alcoholic fatty liver disease (Angulo,
2002; Hossain et al., 2007; Jensen et al., 2008). Increasing evidence indi-
cates that chronic low-grade inﬂammation in peripheral tissues contrib-
utes to HFD-mediated obesity and insulin resistance. HFD increases
plasma levels of saturated fatty acids,which can trigger proinﬂammatorysity, Department of Nutrition &
Science Center, Department of
07-3260, USA.
,
. This is an open access article underresponses through the induction of NF-ĸB and JNK signaling. Thus, the
precise modulation of free fatty acid levels and inﬂammatory signaling
are vital for the maintenance of metabolic homeostasis.
Cell-autonomous circadian clocks in peripheral tissues are involved
in the regulation of inﬂammatory responses andmetabolic homeostasis.
Endogenous clocks in immune cells provide for the circadian control of
their abundance in the circulation, production of inﬂammatory factors,
and functional responses to inﬂammatory challenge (Keller et al.,
2009; Lange et al., 2010). Tissue- and cell-speciﬁc clocks also provide
for the local coordination of circadian rhythms in the metabolism of
fatty acids (Stenvers et al., 2012). For example, circulating levels of
free fatty acids and adipose tissue expression of genesmediating lipoly-
sis and fatty acid biosynthesis or transport are characterized by clock-
controlled rhythmicity (Shostak et al., 2013). Moreover, genetic or envi-
ronmental disruption of circadian clock function has been shown to po-
tentiate inﬂammatory responses and to produce obesity and other
metabolic disorders (Turek et al., 2005; Marcheva et al., 2010; Gibbs
et al., 2012; Paschos et al., 2012). Our recent ﬁndings demonstratethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Effects of prolonged PUFA and SFA treatment on ensemble Bmal1-dLuc rhythms in
cultured ﬁbroblasts. Individual recordings of ensemble bioluminescence (expressed as
detrended baseline-subtracted counts per second) from representative cultures of
Bmal1-dLuc ﬁbroblasts treated with: (A) BSA (n = 6) or 150 μM DHA (n = 8), and
(B) BSA (n = 6) or 150 μM palmitate (n = 8). Bar graphs depict comparisons of the
circadian period (mean + SEM) of the Bmal1-dLuc rhythms in BSA control and DHA- or
palmitate-treated ﬁbroblasts. Asterisk indicates that the period of the Bmal1-dLuc
rhythms in palmitate-treated cultures was signiﬁcantly greater (p b 0.05) than that in
BSA controls.
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induced tissue inﬂammation, adiposity, and systemic insulin dysregula-
tion (Xu et al., 2014).
While the hierarchy of circadian clocks throughout the body is clear-
ly involved in regulating inﬂammatory andmetabolic processes, this in-
teraction is not strictly unidirectional as inﬂammatory signals and fatty
acid metabolism have been conversely implicated in the feedbackmod-
ulation of the circadian clock mechanism. In this regard, the cytokines,
TNF-α and IL-1β induce phase delays and HFD increases the free-
running period of the activity rhythm in mice (Kohsaka et al., 2007;
Leone et al., 2012; Xu et al., 2014). Thus, mutual interactions between
circadian clocks and key mediators of inﬂammation may be important
in maintaining metabolic homeostasis and in linking clock dysregula-
tion and metabolic phenotypes in diet-associated obesity. Because
inﬂammatory responses and corresponding metabolic disturbances in
diet-induced obesity are differentially engaged by speciﬁc types of
fatty acids found in HFDs, we compared the differential effects of palmi-
tate, the prevalent proinﬂammatory SFA in HFD versus the anti-
inﬂammatory, PUFA DHA on circadian clock function. The extent of
the coupling between diet-mediated inﬂammatory responses and alter-
ations in fundamental clock properties was examined by analyzing the
phase-shifting effects of acute palmitate and DHA treatment at different
times throughout the circadian cycle and then determining their coinci-
dence with fatty acid-mediated induction of inﬂammatory signaling. To
examine the role of inﬂammatory signaling in themechanism bywhich
SFAs modulate clock properties, experiments were also conducted to
determine whether inhibition of proinﬂammatory responses blocks
palmitate-induced phase shifts of peripheral circadian clocks.
2. Materials and Methods
2.1. Cell Culture
Bmal1-dLuc ﬁbroblasts (Dr. Andrew Liu, University of Memphis,
Memphis, TN; Ramanathan et al., 2012) were propagated on 60 mm
dishes in Dulbecco's Modiﬁed Eagle Medium (DMEM; HyClone) con-
taining 292 μg/ml L-glutamine, 10% Fetal Bovine Serum (FBS),
100 units/ml penicillin, and 100 μg/ml streptomycin and maintained
at 37 °C and 5% CO2. Medium was replaced every 48 h and cultures
were split 1:4 every 3 days. As established previously (Huo et al.,
2010, 2012), adipocytes were differentiated from Bmal1-dLuc ﬁbro-
blasts maintained in DMEM containing 10 μg/ml insulin, 1 μM dexa-
methasone, and 0.5 mM 3-isobutyl-1-methylxanthine for 48 h, and
then incubated for 4 additional days in medium supplemented with
10 μg/ml insulin. Following differentiation, adipocytes weremaintained
for 2 days in normal growthmedium prior to experimentation. Cell dif-
ferentiation into adipocytes was veriﬁed by positive staining with Oil
Red O (Fig. S1A) and by upregulated expression of PPARγ and
adiponectin (Fig. S1B). While our analysis of these phenotypic markers
indicates that Bmal1-dLuc ﬁbroblasts exhibit many adipocyte-like prop-
erties following differentiation, it is unclear whether the cells are fully
differentiated intomature adipocytes, thuswarranting their subsequent
designation as ‘differentiated adipocytes’.
2.2. Fatty Acid/Drug Preparation and Treatment
Palmitate (Sigma) and DHA (Nu-Chek-Prep, Inc.) were dissolved in
ethanol and then diluted (1:5.4 ratio) with 10% BSA (fatty acid-free
and low endotoxin) diluted in 0.1 M phosphate-buffered saline (PBS).
Palmitate and DHA treatment in these studies was based on physiolog-
ical concentrations that have been previously observed in vivo or used
for in vitro studies (Ajuwon and Spurlock, 2005; Han et al., 2010; Puri
et al., 2009; Weldon et al., 2007). Controls for fatty acid treatment
contained BSA diluted in PBS with an equivalent ratio of ethanol.
AICAR (Tocris) or cardamonin (Tocris) were dissolved in DMSO and
then diluted 1:400 and 1:10000 in culture medium to achieve ﬁnalconcentrations of 500 μM or 5 μM, respectively. Vehicle controls for
AICAR and cardamonin treatment consisted of cultures in which an
equivalent amount of DMSO was added to the medium.
2.3. Effect of Prolonged Fatty Acid Treatment on Circadian Period
Bmal1-dLuc ﬁbroblasts were plated onto 35 mm dishes and≈24 h
later treated with either BSA (10% in PBS with EtOH), palmitate
(150 μM), or DHA (150 μM) for 48 h. Following fatty acid treatment, cul-
tures were rinsed and thenmaintained in recordingmedia for 6–7 days
during real-time analysis of Bmal1-dLuc bioluminescence.
2.4. Time-dependent Variation in the Phase Shifting and Proinﬂammatory
Effects of Acute Fatty Acid Treatment
Bmal1-dLuc ﬁbroblast cultures on 35 mm dishes were exposed for
2 h to medium containing 15 μM forskolin to facilitate circadian oscilla-
tion synchronization across cultures (Menger et al., 2007) and then
treated for 4 h with BSA (10% in PBS with EtOH), palmitate (250 μM)
or DHA (250 μM) at 6 h intervals throughout the circadian cycle. Cul-
tures were subjected to control or fatty acid treatments at 6, 12, 18 or
24 h after forskolin administration and then placed in recording media
for bioluminescence analysis of treatment-induced phase shifts of
Bmal1-dLuc oscillations.
For parallel analyses of inﬂammatory responses to acute fatty acid
treatment, conﬂuent cultures of Bmal1-dLuc ﬁbroblasts on 6-well plates
were exposed for 2 h to 15 μM forskolin and then 6, 12, 18 or 24 h later
102 S.-M. Kim et al. / EBioMedicine 7 (2016) 100–111treated with BSA, palmitate (250 μM) or DHA (250 μM) for 4 h. After
treatment, cells were rinsed, collected, frozen in liquid nitrogen and
stored at−80 °C for subsequent analyses of NF-ĸB activation or cyto-
kine mRNA expression.
2.5. Effect of Inﬂammatory Signaling Inhibitors on Fatty Acid-induced Phase
Shifts of the Circadian Clock
Real-time analysis of cells transfected with an inducible NF-kB-
responsive GFP construct was used to test whether treatment with
DHA, AICAR, or cardamonin, a chalconewith anti-inﬂammatory activity
(Ahmad et al., 2006), modulates palmitate-induced inﬂammatory sig-
naling when its phase-shifting effects are maximal. GFP-reported NF-
ĸB activity was quantiﬁed in cells that were treated with: 1) DHA
(50 μM) for 12 h in advance and during exposure to palmitate
(250 μM) for 4 h; or 2) AICAR (500 μM) or cardamonin (5 μM) in con-
junction with palmitate (250 μM) administration for 4 h. Effects of
these anti-inﬂammatory treatments on peak phase-shifting responses
of the Bmal1-dLuc rhythm were examined in parallel cultures that
were similarly treated with DHA, AICAR or cardamonin relative to pal-
mitate exposure at hour 12. Following treatment, cultures were placed
in recording media for bioluminescence analysis of treatment effects
on palmitate-induced phase shifts of Bmal1-dLuc oscillations.Fig. 2. Phase-shifting effects of acute DHA treatment on ensemble Bmal1-dLuc rhythms in cultur
cultures of Bmal1-dLuc ﬁbroblasts treated for 4 h with BSA (n = 4) or 250 μM DHA (n = 8)
dependent phase shifts of ﬁbroblast Bmal1-dLuc rhythms in response to DHA treatment for
DHA treatment (at hours 6, 12, 18 and 24). Phase delays of the ﬁbroblast Bmal1-dLuc rhythm
indicate that phase-shifting responses to DHA at hours 12 and 18 were signiﬁcantly greater (p2.6. Protein Extraction and Western Blot analysis of NF-ĸB Activation
Bmal1-dLuc ﬁbroblasts were lysed in mammalian protein extraction
reagent (Pierce Biotechnology) containing protease and phosphatase
inhibitor cocktail (Thermo Scientiﬁc). Protein content in cell homoge-
nates was measured using the bicinchoninic acid method. NF-ĸB and
phospho-NF-ĸB in cell lysates (10–30 μg protein/lane) were assessed
byWestern blot analysis using 10% Tris-Glycine gels as described previ-
ously (Shende et al., 2013). Membranes were probed with antibodies
against phospho-NF-ĸB (p-p65; Cell Signaling Technology) or NF-ĸB
(p-65; Cell Signaling Technology) followed by incubation with horse-
radish peroxidase-conjugated goat anti-rabbit IgG (Biorad). Densito-
metric analyses of size-appropriate immunoreactive bands were per-
formed using NIH ImageJ software. To control for inter-sample
differences in protein content, p-NF-ĸB signal intensity was normalized
to NF-ĸB values in each sample.
2.7. Real-time Reporter Assay of NF-ĸB Activity
The Cignal NF-ĸB Reporter Assay Kit (Qiagen) was used to quantify
treatment-induced changes in the transcriptional regulatory activity of
NF-ĸB. Cultures of Bmal1-dLuc ﬁbroblasts (70–80% conﬂuent) on
opaque 96-well plates were transfected for 48 h with an inducible NF-edﬁbroblasts. (A) Representative recordings of ensemble bioluminescence from individual
at hours 6, 12, 18 and 24. Red arrows indicate time of BSA or DHA treatment. (B) Time-
4 h. Mean (+SEM) phase shifts (ΔΦ) in hours are plotted as a function of the timing of
are indicated by negative values and advances are denoted by positive values. Asterisks
b 0.05) than those observed during the corresponding minima.
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Lipofectamine® 3000 (Invitrogen). Approximately 24 h after transfec-
tion, cells were exposed to medium containing 15 μM forskolin and
12 h later treatedwith BSA or palmitate for 4 h. Experimental groups in-
cluded cultures treated with: 1) DHA (50 μM) for 12 h in advance and
during exposure to palmitate; or 2) AICAR (500 μM) or cardamonin
(5 μM) in conjunction with palmitate administration. NF-ĸB signaling
activitywas assessed through quantitativemeasurement of GFPﬂuores-
cence and then compared relative to negative controls.
2.8. RNA Extractions and Real-time PCR
Total RNAwas extracted from all cell lysates and relative quantiﬁca-
tion of interleukin-6 (IL-6) mRNA abundance was performed using
SYBR-Green PCR technology [Applied Biosystems Inc. (ABI)] as de-
scribed previously (Farnell et al., 2011; Xu et al., 2014). For each sample,
real-time PCR analysis of IL-6 mRNA was performed on duplicate ali-
quots using the cDNA equivalent of 1 ng of total RNA. To control for dif-
ferences in sample RNA content, β-actin mRNA was ampliﬁed with the
cDNA equivalent of 1 ng total RNA from the same samples. Consistent
with our previous studies (Xu et al., 2014), β-actin mRNA showed no
sign of circadian variation. The comparative CT method was utilized to
calculate the relative abundance for a given cytokinemRNA by normal-
ization to corresponding β-actin levels in each sample and to a calibra-
tor consisting of pooled cDNA from multiple samples.Fig. 3. Phase-shifting effects of acute palmitate (PAL) treatment on ensemble Bmal1-dLuc rhythm
individual cultures of Bmal1-dLuc ﬁbroblasts treated for 4 h with BSA (n = 5–6) or 250 μM PA
(B) Time-dependent phase shifts (mean ± SEM) of ﬁbroblast Bmal1-dLuc rhythms in respo
shifting responses to PAL at hour 12 were signiﬁcantly greater (p b 0.05) than those observed2.9. Real-time Analysis of Bmal1-dLuc Rhythms
Prior to bioluminescence analysis, growthmediumwas removed and
cultures were placed in DMEM recording medium containing 1 μM
forskolin, 25 mM HEPES, 292 μg/ml L-glutamine, 100 units/ml
penicillin, 100 μg/ml streptomycin and 100 μM luciferin (Promega). Cul-
tures were sealed airtight with sterile glass coverslips, and sterile silicon
grease. The temporal patterns of Bmal1-dLuc bioluminescence were ana-
lyzed using an automated 32-channel luminometer (LumiCycle;
Actimetrics) housed in a standard culture incubator at 35 °C. Biolumines-
cence from individual cultureswas continuously recorded for ~70 s at in-
tervals of 10 min. Rhythm parameters were determined from baseline-
subtracted data using the damped sine ﬁt and Levenberg–Marquardt al-
gorithm. The amplitude of phase shifts in response to fatty acid treat-
ment was determined by measuring the time difference between the
peaks of theBmal1-dLuc rhythmsduring the third cycle in BSAor BSA/ve-
hicle (DMSO) control and experimental treatment groups.
2.10. Statistical Analysis
Independent t-testswere performed to determine the signiﬁcance of
treatment effects (DHA, palmitate, AICAR, or cardamonin relative to ve-
hicle controls) on NF-κB activity, IL-6 expression and palmitate-induced
phase shifts. In each case, the α-value was set at 0.05. Time-dependent
differences in phase-shifting effects of DHA or palmitate on the Bmal1-s in culturedﬁbroblasts. (A) Representative recordings of ensemblebioluminescence from
L (n = 5–6) at hours 6, 12, 18 and 24. Red arrows indicate time of BSA or PAL treatment.
nse to PAL treatment at hours 6, 12, 18 and 24. The asterisk indicates that peak phase-
during the corresponding minima.
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(ANOVA). Paired comparisons between peak phase-shifting responses
and the corresponding minima were analyzed post-hoc for statistical
differences using the Student Newman–Keuls sequential range test.
The α-value was set at 0.05 for these post-hoc analyses.
3. Results
3.1. Effect of Prolonged Fatty Acid Treatment on Circadian Period
Given that HFD feeding induces pronounced alterations in circadian
timekeeping in peripheral clocks (Xu et al., 2014), we ﬁrst determined
whether prolonged treatment with palmitate, the prevalent SFA in
HFD, similarly affects clock gene oscillations in Bmal1-dLuc ﬁbroblasts
in vitro. All BSA-, DHA- and palmitate-treated ﬁbroblast cultures exhib-
ited circadian rhythms of Bmal1-dLuc bioluminescence that persisted at
least 4–5 cycles (Fig. 1). The period of the Bmal1-dLuc rhythms in cul-
tures exposed to DHA for 48 h was greater (by≈0.4 h) but not signiﬁ-
cantly different (p = 0.14) relative to that observed in BSA-treated
controls (Fig. 1A). In contrast, palmitate-treated ﬁbroblast cultures
were distinguished by Bmal1-dLuc rhythms inwhich the periodwas sig-
niﬁcantly increased (p N 0.05) by≈3 h in comparison to BSA controls
(Fig. 1B). Palmitate treatment also had a distinct effect in reducing
rhythm amplitude to≈40% of control values.Fig. 4. Phase-shifting effects of acuteDHA treatment on ensemble Bmal1-dLuc rhythms in culture
from individual cultures of differentiated Bmal1-dLuc adipocytes treated for 4 h with BSA (
approximate time at which cultures were exposed to BSA or DHA. (B) Time-dependent phase
hours 6, 12, 18 and 24.3.2. Time-dependent Variation in the Phase Shifting and Proinﬂammatory
Effects of Acute Fatty Acid Treatment
In response to acute (4 h) treatment at hours 6, 12, 18 and 24 with
250 μMDHA or palmitate, the period of the Bmal1-dLuc rhythms in cul-
tures of undifferentiated ﬁbroblasts was not signiﬁcantly different from
that observed in experiment-matched BSA controls. Phase shifting anal-
ysis revealed that DHA had negligible effects on the Bmal1-dLuc rhythm
at hours 6 and 24 whereas treatment at hours 12 and 18 induced small
phase delays of about 0.5 h (Fig. 2). Following bioluminescence analysis,
no differences in cell viability were evident in cultures treated with
250 μM DHA. Similar to DHA, acute palmitate treatment shifted the
phase of ﬁbroblast Bmal1-dLuc rhythms in a time-dependent manner,
but the directionality of these shifts was different and their amplitude
was much larger (Fig. 3). At hours 12 and 18 when DHA induced
small phase delays, palmitate produced the opposite effect: phase ad-
vances of ﬁbroblast Bmal1-dLuc rhythms. Peak phase-shifting responses
to palmitate were observed at hour 12 when treatment induced large
phase advances of ≈2.5 h. Palmitate treatment at hour 18 also pro-
duced clear phase advances of the Bmal1-dLuc rhythm although the am-
plitude (≈1 h)was reduced relative to its phase-shifting effects at hour
12. Palmitate-induced phase shifts were minimal at hours 6 and 24,
with treatment inducing small advances and delays of≈0.5 h respec-
tively at these timepoints. Unlike prolonged exposure, acute treatments of differentiated adipocytes. (A) Representative recordings of ensemble bioluminescence
n = 4) or 250 μM DHA (n = 5–10) at hours 6, 12, 18 and 24. Red arrows indicate the
shifts (mean ± SEM) of adipocyte Bmal1-dLuc rhythms in response to DHA treatment at
105S.-M. Kim et al. / EBioMedicine 7 (2016) 100–111withDHAor palmitate had little or no consistent effect on the amplitude
of the Bmal1-dLuc rhythm.
To determine whether DHA or palmitate phase shift clock gene
rhythms in other peripheral cell types and whether the time-
dependent nature of phase-shifting responses differs among peripheral
circadian clocks, parallel analysis was performed on adipocytes differ-
entiated from Bmal1-dLuc ﬁbroblasts. Irrespective of treatment time,
DHA had little or no phase-shifting effects on the Bmal1-dLuc rhythm
in differentiated adipocytes (Fig. 4). DHA produced small phase ad-
vances (≈0.25 h) at hour 6 and phase delays (≈0.2 h) at hour 12
whereas phase-shifting effects of this PUFA were marginal (b0.1 h) at
hours 18 and 24. Similar to its effects on undifferentiated ﬁbroblasts,
acute palmitate treatment shifted the phase of adipocyte Bmal1-dLuc
rhythms (Fig. 5). However, the time-dependent variation in adipocyte
phase-shifting responses to palmitate was markedly different from the
pattern in undifferentiated ﬁbroblasts. Palmitate-induced phase shifts
in differentiated adipocytes were maximal at hour 6, when treatment
had negligible effects on the phase of undifferentiated ﬁbroblast
Bmal1-dLuc rhythms. At hour 6, palmitate advanced the phase of adipo-
cyte Bmal1-dLuc rhythms by≈4 h. In differentiated adipocyte cultures,
palmitate also induced small phase advances (≈1.3 h) at hour 12 but
had minimal effects on the Bmal1-dLuc rhythm at hours 18 and 24,Fig. 5. Phase-shifting effects of acute palmitate (PAL) treatment on ensemble Bmal1-dLuc rhy
bioluminescence from individual cultures of differentiated Bmal1-dLuc adipocytes treated f
indicate time of BSA or PAL treatment. (B) Time-dependent phase shifts (mean ± SEM) of diff
and 24. The asterisk indicates that peak phase-shifting responses to PAL at hour 6 were signiﬁcproducing phase delays of less than 0.7 h. Bmal1-dLuc rhythms in differ-
entiated adipocytes showed no clear signs of DHA- or palmitate-
induced changes in amplitude.
Since SFAs trigger NF-κB-mediated signaling that leads to the induc-
tion of proinﬂammatory cytokines (Ajuwon and Spurlock, 2005;
Maloney et al., 2009; Wang et al., 2012), we next determined whether
the effects of palmitate on these key mediators of fatty acid-induced in-
ﬂammation are both time-dependent and coincident with the temporal
variation in the phase-shifting responses of the clockmechanism to this
SFA. Consistent with previous reports (Novak et al., 2003; Gladine et al.,
2014), acute DHA treatment had no effect on NF-κB activation butmod-
ulated expression of the proinﬂammatory cytokine IL-6 in Bmal1-dLuc
ﬁbroblasts. In cultures treated with DHA at hours 6, 12, 18 or 24, levels
of NF-κB phosphorylation (Fig. 6A)were not signiﬁcantly different from
those in time-matched BSA controls. However, DHA administration at
hours 12, 18 and 24 induced signiﬁcant decreases (p b 0.05) in IL-6
mRNA expression (≈40–75%) relative to BSA-treated ﬁbroblasts
(Fig. 6B). In contrast to DHA, palmitate induced both NF-κB signaling
and IL-6 mRNA expression in Bmal1-dLuc ﬁbroblasts in a time-
dependent manner. Relative to BSA-treated cultures, palmitate induced
signiﬁcant increases (p b 0.05) in NF-ĸB phosphorylation at hours 12
and 18 but not at hours 6 and 24 (Fig. 7A), coinciding with the temporalthms in cultures of differentiated adipocytes. (A) Representative recordings of ensemble
or 4 h with BSA (n = 6) or 250 μM PAL (n = 6) at hours 6, 12, 18 and 24. Red arrows
erentiated adipocyte Bmal1-dLuc rhythms in response to PAL treatment at hours 6, 12, 18
antly greater (p b 0.05) than those observed during the corresponding minima.
Fig. 7. Time-dependent effects of acute palmitate (PAL) treatment on inﬂammatory
signaling in Bmal1-dLuc ﬁbroblasts. (A) Representative Western blot and densitometric
quantiﬁcation (mean ± SEM) of P-p65/p65 immunoreactive signal (% Control) in
ﬁbroblast cultures treated for 4 h with BSA (n = 3) or 250 μM PAL (n = 3) at hours 6,
12, 18 and 24. (B) IL-6 mRNA expression (mean ± SEM) in parallel groups of BSA- and
PAL-treated ﬁbroblast cultures. Asterisks denote treatment times in which NF-κB
phosphorylation or the relative expression of IL-6 mRNA in PAL-treated ﬁbroblasts were
signiﬁcantly increased (p b 0.05) compared to that found in control cultures.
Fig. 6. Time-dependent effects of acute DHA treatment on inﬂammatory signaling in
Bmal1-dLuc ﬁbroblasts. (A) Representative Western blot and densitometric analyses of
NF-κB-mediated inﬂammatory signaling in ﬁbroblast cultures treated for 4 h with BSA
(n = 3) or 250 μM DHA (n = 3) at hours 6, 12, 18 and 24. Bar graphs depict the ratios
of P-p65/p65 immunoreactive signal that were adjusted in relation to control (BSA)
values (% Control). (B) Real-time PCR determinations (mean ± SEM) of IL-6 mRNA
expression in parallel groups of BSA- and DHA-treated ﬁbroblast cultures. Plotted values
correspond to the ratio of IL-6 mRNA signal normalized to β-actin mRNA levels in each
sample and adjusted relative to the averages of time-matched BSA controls, which were
set at 100%. Asterisks denote treatment times in which the relative expression of IL-6
mRNA in DHA-treated ﬁbroblasts was signiﬁcantly decreased (p b 0.05) in comparison
with that found in BSA controls.
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Palmitate-induced IL-6 expression in Bmal1-dLuc ﬁbroblasts provided
further evidence of the close temporal coincidence between proinﬂam-
matory and phase-shifting responses to treatment; in palmitate-treated
cultures, IL-6mRNA expressionwas signiﬁcantly increased (p b 0.05) by
180–225% at hours 12 and 18 relative to BSA controls but this inductive
effect was blunted (≈135%) at hours 6 and 24 (Fig. 7B).
The effects of acute DHA treatment on NF-κB activation and IL-6 ex-
pression in differentiated adipocytes were similar to those observed in
undifferentiated ﬁbroblasts. Following administration at hours 6, 12,
18 and 24, DHA-treated adipocyte cultures and time-matched BSA con-
trols exhibited no signiﬁcant differences in levels of NF-κB phosphoryla-
tion (Fig. 8A). However, IL-6 mRNA expression was signiﬁcantly
decreased (p b 0.05) by≈60–70% in response to DHA administration
at hours 12, 18 and 24 relative to that observed in BSA-treated adipo-
cytes (Fig. 8B). At hour 6, IL-6mRNA expression inDHA-treated cultureswas decreased but not signiﬁcantly different in comparison to time-
matched controls. In differentiated adipocytes, palmitate treatment pro-
duced time-dependent increases in both NF-κB activation and IL-6
mRNA expression. Peak induction of NF-ĸB phosphorylation was ob-
served in response to palmitate administration at hour 6 (Fig. 9A),
when phase-shifting responses to this SFAweremaximal in differentiat-
ed adipocytes. Relative to time-matched BSA controls, palmitate in-
duced signiﬁcant increases (p b 0.05) in NF-ĸB activation not only at
hour 6 but also at hour 24. NF-κB phosphorylation in palmitate-
treated adipocyte cultures was moderately elevated at hour 12 but un-
changed at hour 18 in comparison with the levels observed in BSA con-
trols. The effects of palmitate on IL-6 expression in differentiated
adipocytes closely coincided with the timing of peak phase-shifting re-
sponses to this SFA. Palmitate had no signiﬁcant effect on IL-6 mRNA
levels following administration at hours 12, 18 and 24 (Fig. 9B) but sig-
niﬁcantly increased (p b 0.05) expression of this proinﬂammatory cyto-
kine (≈188%) at hour 6, when treatment induced maximal phase
advances of adipocyte Bmal1-dLuc rhythms.
Fig. 9. Time-dependent effects of acute palmitate (PAL) treatment on inﬂammatory
signaling in differentiated Bmal1-dLuc adipocytes. (A) Representative Western blot and
densitometric quantiﬁcation (mean ± SEM) of P-p65/p65 immunoreactive signal (%
Control) in differentiated adipocyte cultures treated for 4 h with BSA (n = 3) or 250 μM
PAL (n = 3) at hours 6, 12, 18 and 24. (B) IL-6 mRNA expression (mean ± SEM) in
parallel groups of BSA- and PAL-treated differentiated adipocyte cultures. Asterisks
denote treatment times in which NF-κB phosphorylation or the relative expression of IL-
6 mRNA in PAL-treated differentiated adipocytes were signiﬁcantly increased (p b 0.05)
compared to that found in control cultures.
Fig. 8. Time-dependent effects of acute DHA treatment on inﬂammatory signaling in
differentiated Bmal1-dLuc adipocytes. (A) Representative Western blot and densitometric
quantiﬁcation (mean ± SEM) of P-p65/p65 immunoreactive signal (% Control) in
differentiated adipocyte cultures treated for 4 h with BSA (n = 3) or 250 μM DHA (n =
3) at hours 6, 12, 18 and 24. (B) Determinations (mean ± SEM) of IL-6 mRNA expression
in parallel groups of BSA- and DHA-treated differentiated adipocyte cultures. Asterisks
denote treatment times in which the relative expression of IL-6 mRNA in DHA-treated
differentiated adipocytes was signiﬁcantly decreased (p b 0.05) in comparison with that
found in BSA controls.
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Shifts of the Circadian Clock
To examine the role of inﬂammatory signaling in themechanism by
which palmitate modulates circadian clock function, we next deter-
mined whether the omega-3 fatty acid DHA and other inhibitors of in-
ﬂammation abate peak inﬂammatory and phase-shifting responses to
this SFA at hour 12 in Bmal1-dLuc ﬁbroblasts. Because AMPK plays a
role in regulating fatty acid oxidation and inhibitingNF-ĸB-mediated in-
ﬂammatory responses (Salminen et al., 2011), the AMPK activator,
AICAR, was utilized in parallel to inhibit palmitate-induced inﬂammato-
ry signaling. Consistentwith previous reports on AMPK regulation in re-
sponse to palmitate and other SFAs (Sun et al., 2008; Lindholm et al.,
2013), phospho-AMPK activity was signiﬁcantly decreased (p b 0.05)
in Bmal1-dLuc ﬁbroblasts treated with palmitate and was signiﬁcantly
increased (p b 0.05) following exposure to AICAR alone (Fig. S2). Palmi-
tate administration at hour 12 induced a 35–40% increase in GFP-reported NF-κB activation in Bmal1-dLuc ﬁbroblasts, but treatment
with DHA (Fig. 10A), AICAR (Fig. 10B) or cardamonin (Fig. 10C) signiﬁ-
cantly inhibited (p b 0.05) the inductive effects of this SFA on NF-κB
such that signaling activity was comparable to the basal levels found
in vehicle/BSA controls. Treatment with DHA, AICAR or cardamonin
similarly inhibited the phase-shifting responses of Bmal1-dLuc ﬁbro-
blasts to palmitate. In DHA-treated cultures, palmitate-induced phase
shifts of the Bmal1-dLuc rhythm were signiﬁcantly decreased
(p b 0.05) relative to those observed in controls (Fig. 11A). Administra-
tion of palmitate alone produced 2.5-hour phase advances in vehicle-
pretreated controls whereas the amplitude of these shifts was reduced
by 70% following pretreatment with DHA. Little or no phase-shifting ef-
fect was observed in response to DHA alone (+BSA at hour 12). Similar
to the effects of DHA, AICAR signiﬁcantly decreased (p b 0.05) the
phase-shifting responses of ﬁbroblast Bmal1-dLuc rhythms to palmitate
administration at hour 12 (Fig. 11B). Once again, palmitate alone in-
duced large phase advances of≈2.8 h in vehicle-pretreated cultures.
In comparison, the amplitude of these palmitate-induced phase shifts
Fig. 10. Effects of DHA (A), AICAR (B) or cardamonin (C) treatment on NF-κB-regulated inﬂammatory responses of Bmal1-dLuc ﬁbroblasts to palmitate (PAL; 250 μM). Bar graphs depict
real-time ﬂuorometric analysis of cells transfected with an inducible NF-κB-responsive GFP construct that were treated with DHA (50 μM), AICAR (500 μM) or cardamonin (5 μM) in
advance of and/or during palmitate (250 μM) administration for 4 h at hour 12. Effects of treatment with DHA, AICAR or cardamonin alone (DHA + BSA, AICAR + BSA, CARD + BSA)
on NF-κB activity were also tested. Control cultures were treated with BSA or vehicle (DMSO) and BSA (VEH + BSA). Plotted values denote determinations of GRP signal intensity
(mean ± SEM) in each treatment group (n = 5) that were normalized to the average signal for controls, which was arbitrarily set at 100%. Asterisks indicate that palmitate-induced
NF-κB activity was signiﬁcantly decreased (p b 0.05) in Bmal1-dLuc ﬁbroblasts treated with DHA (DHA + PAL), AICAR (AICAR + PAL) or cardamonin (CARD + PAL) in comparison
with those exposed to palmitate alone (BSA + PAL or VEH + PAL).
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of AICAR alone were minimal as only small advances of the Bmal1-dLuc
rhythm (b0.5 h) were observed in cultures treated with BSA and AICAR
at hour 12. Concurrent treatment with cardamonin, an anti-
inﬂammatory chalconoid that inhibits LPS-stimulated NF-κB signaling
(Chow et al., 2012), also had a signiﬁcant effect (p b 0.05) in repressing
palmitate-induced phase shifts of ﬁbroblast Bmal1-dLuc rhythms at
hour 12. Palmitate induced phase advances of≈2 h in vehicle-treated
cultures but only advanced Bmal1-dLuc rhythms by 0.5 h or less in cul-
tures concurrently treated with cardamonin (Fig. 11C). Treatment with
cardamonin alone (+BSA at hour 12) induced small phase delays
(≈1 h).
4. Discussion
While circadian clocks throughout the body clearly play a role in reg-
ulating metabolic pathways and their homeostatic function, increasing
evidence for diet-induced alterations in clock gene oscillations and be-
havioral rhythms suggests that nutrient metabolism may, in turn, feed
back on the clock mechanism and modulate fundamental properties
of circadian rhythms. HFD has been shown to alter circadian timekeep-
ing function although its effects vary greatly among clocks in the brain
and peripheral tissues. For example, HFD had no effect on core clock
gene oscillations in the hypothalamus and only produced small in-
creases in the free-running period of the SCN-regulated rhythm of loco-
motor activity (Kohsaka et al., 2007; Xu et al., 2014). Consistentwith the
effects of HFD on circadian clocks in the brain, palmitate alters clock
gene expression and the amplitude of their rhythmic proﬁles in a hypo-
thalamic cell line and this effect is not accompanied by a corresponding
induction of inﬂammatory cytokines such as IL-6 (Fick et al., 2011;
Greco et al., 2014). In contrast, HFD-induced dysregulation of circadian
timekeeping is more robust in peripheral clocks; in HFD-fed mice,
clock gene oscillations are distinguished by severe damping in both
liver and fat tissue (Kohsaka et al., 2007) and by circadian period in-
creases of up to 9 h in adipose tissue and bone marrow-derived macro-
phages (Xu et al., 2014). Similar to the latter effect of HFD, prolonged
treatment with palmitate induced large increases in the period of ﬁbro-
blast Bmal1-dLuc rhythms, suggesting that this proinﬂammatory SFA is
a key mediator of HFD-induced modulation of peripheral circadian
clocks.
Importantly, our ﬁndings indicate that the effects of HFD and its
major constituent, palmitate, on circadian clock properties are not lim-
ited to changes in period and rhythm amplitude, but include differential
phase shifts of clock gene oscillations in peripheral tissues. Previousstudies have established that phase-shifting responses to HFD again dif-
fer among peripheral and central circadian clocks. In this regard, HFD
treatment for 7 days has been shown to shift Per2 oscillations, producing
large advances in the liver and small delays in the spleen but no effect
on the phase of SCN rhythms (Pendergast et al., 2013). In the present
study, 4-hour exposure of peripheral cell types to palmitate similarly in-
duced marked phase shifts of clock gene oscillations that varied in am-
plitude depending on the time of treatment. It is noteworthy that the
time-dependent nature of palmitate-mediated phase shifts of the
Bmal1 rhythmwas cell-speciﬁc; the phase responses of undifferentiated
ﬁbroblasts to this proinﬂammatory SFA were maximal at hour 12 and
negligible at hour 6 when palmitate-induced phase advances were at
peak amplitude in differentiated adipocytes. Because the omega-3
fatty acid DHA had little or no phase-shifting effects on clock gene oscil-
lations in both ﬁbroblasts and differentiated adipocytes, these ﬁndings
collectively suggest that SFAs may differentially reset the clock mecha-
nism in some but not all cells within a given tissue, thereby altering
the local coordination of circadian timekeeping among individual cellu-
lar clocks.
How HFD and palmitate modulate circadian timekeeping is un-
known. The present evidence for the close coincidence between the
time-dependent variation in inﬂammatory and phase-shifting re-
sponses to palmitate raises the possibility that mutual interactions be-
tween peripheral circadian clocks and inﬂammatory signaling
pathways may play a key role in the underlying mechanism. In both
Bmal1-dLuc ﬁbroblasts and differentiated adipocytes, the maxima and
minima for palmitate-induced inﬂammatory signaling were contempo-
raneous with the equivalent variation in the amplitude of the phase
shifts induced by this SFA. Thus, the signaling cascades through which
HFD and SFAs induce inﬂammation in peripheral tissues may govern
the modulatory effects of palmitate on circadian timekeeping. The in-
duction of inﬂammatory signaling by palmitate and other SFAs is medi-
ated through activation of NF-κB, ultimately leading to the secretion of
proinﬂammatory cytokines in various peripheral tissues (Weigert
et al., 2004; Ajuwon and Spurlock, 2005; Jové et al., 2006). In addition,
the nutrient sensor, AMP-activated protein kinase (AMPK), is involved
in coupling fatty acid metabolism to inﬂammatory responses. Palmitate
and other SFAs decrease AMPK activity (Sun et al., 2008; Lindholm et al.,
2013) and correspondingly their inductive effects on NF-κB activation
and the expression of proinﬂammatory cytokines are repressed by
AMPK activators (Yang et al., 2010; Green et al., 2011). The role of in-
ﬂammatory signaling in SFA-mediated phase regulation of peripheral
circadian clocks is directly supported by the present ﬁndings that the
anti-inﬂammatory inhibitor of NF-ĸB signaling, cardamonin, and the
Fig. 11. Effects of DHA (A), AICAR (B) or cardamonin (C, CARD) treatment on the phase-shifting responses of Bmal1-dLuc ﬁbroblasts to palmitate (PAL). Representative recordings of
ensemble bioluminescence from individual ﬁbroblast cultures treated with either vehicle (VEH; DMSO), DHA (50 μM) for 12 h in advance or AICAR (500 μM) or cardamonin (5 μM)
for 4 h in conjunction with PAL administration (250 μM) for 4 h at hour 12. Phase-shifting effects of these anti-inﬂammatory treatments alone were also tested in BSA control cultures
treated with DHA for 12 h, or with AICAR or cardamonin for 4 h. Speciﬁc experimental groups include: BSA + BSA or VEH + BSA (n = 15), BSA + PAL or VEH + PAL (n = 18),
DHA + PAL (n = 6), DHA + BSA (n = 6), AICAR + PAL (n = 10), AICAR + BSA (n = 8), CARD + PAL (n = 6) and CARD + BSA (n = 6). Red arrows denote time of palmitate
administration after 12 h pretreatment with DHA (adjacent shaded area in A) or during AICAR (B) or cardamonin treatment (C). Bar graphs depict the mean (±SEM) phase shifts
(ΔΦ) in hours as a function of treatment group. Asterisks indicate that palmitate-induced phase shifts were signiﬁcantly decreased (p b 0.05) in Bmal1-dLuc ﬁbroblasts treated with
DHA (DHA+ PAL), AICAR (AICAR + PAL) or cardamonin (CARD + PAL) in comparison with those observed in controls (VEH + PAL).
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and phase-shifting responses to palmitate at hour 12. Because DHA re-
presses inﬂammation-induced NF-ĸB signaling and cytokine expression
via activation of AMPK (Xue et al., 2012), the observed inhibition of
palmitate-induced inﬂammation and phase shifts following pretreat-
mentwith this PUFA also underscores the importance of clock-gated in-
ﬂammatory signaling in the mechanism by which palmitate alters
circadian timekeeping. In conjunction with evidence for the circadian
regulation of AMPK activity (Um et al., 2011) and inﬂammatory re-
sponses of theNF-ĸB pathway (Spengler et al., 2012) in different tissues,
these observations indicate that mutual interactions between peripher-
al clocks and inﬂammatory signaling mediate the time-dependentvariation in the extent to which SFA overload triggers inﬂammation
and in turn, leads to the feedback modulation of circadian timekeeping.
The endoplasmic reticulum (ER) stress pathway may also be in-
volved in the palmitate-mediated regulation of circadian clock proper-
ties. Recent evidence supports a link between the circadian clock and
ER homeostasis involving mutual regulation of each other (Pluquet
et al., 2014). Moreover, SFAs such as palmitate induce ER stress via mul-
tiple mechanisms (Milanski et al., 2009; Baldwin et al., 2012; Ariyama
et al., 2010) whereas the omega-3 fatty acid DHA attenuates ER stress
(Kolar et al., 2011). Because ER stress has been linked to inﬂammation
in metabolic disorders (Cao et al., 2016), further studies are needed to
determine whether ER stress plays a role in palmitate-mediated
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with, the inductive effects of this SFA on inﬂammatory signaling.
The association between circadian clock dysfunction and metabolic
disorders is largely based on studies that involve the complete disrup-
tion of rhythmicity using genetic or environmental approaches. Howev-
er, the present data have novel implications for how differential and
cell-speciﬁcmodulation, rather than completemalfunction, of peripher-
al circadian clocksmay be germane factors in the ampliﬁcation of proin-
ﬂammatory responses to HFD and SFA excess that are closely linked to
systemic metabolic dysregulation. In both ﬁbroblasts and differentiated
adipocytes, palmitate-mediated inﬂammatory signaling is gated rhyth-
mically and at times of peak induction, provides feedback that modu-
lates the phase of the core clock mechanism. Because the phase-
shifting responses to palmitate appear to differ among peripheral cell
types, this feedback modulation is likely to disrupt the local coordina-
tion of circadian timekeeping among cell-autonomous clocks within a
given tissue, thus further potentiating SFA-induced inﬂammation that
contributes to systemic insulin resistance. The palmitate-induced in-
ﬂammatory signals directly responsible for the feedback modulation
of circadian phase remain to be determined, but future studies are war-
ranted to examine the role of proinﬂammatory cytokines such as IL-6 in
mediating the phase-shifting effects of this SFA. Finally, these interac-
tions between peripheral circadian clocks and pathways linking fatty
acid metabolism to tissue inﬂammation suggest that chronotherapeutic
strategies using DHA and/or metformin, an AMPK agonist exploited in
the treatment of hyperglycemia in type II diabetes (Akbar, 2003), may
be critical in the management of metabolic diseases associated with
fatty acid overload.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2016.03.037.
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